Literature DB >> 16807304

Mobilisation of mesenchymal cells into blood in response to skeletal muscle injury.

M Ramírez1, A Lucia, F Gómez-Gallego, J Esteve-Lanao, A Pérez-Martínez, C Foster, A L Andreu, M A Martin, L Madero, J Arenas, J García-Castro.   

Abstract

Mesenchymal cells recruited to damaged tissues must circulate through the bloodstream. The absolute numbers of circulating mesenchymal stem cells (cMSCs) in two different models of acute and chronic skeletal muscle injury were determined. cMSCs were present in significantly higher numbers in both models than in healthy controls. These results support the hypothesis that MSCs are mobilised into the bloodstream after skeletal muscle tissue damage. These two models (acute and chronic) would be of value in the search for molecular mediators of mobilisation of MSCs into the circulation.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16807304      PMCID： PMC2579469          DOI： 10.1136/bjsm.2006.028639

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN： 0306-3674            Impact factor:   13.800


  17 in total

1.  Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells.

Authors:  P A Conget; J J Minguell
Journal:  J Cell Physiol       Date:  1999-10       Impact factor: 6.384

2.  Myopathy due to a defect in muscle glycogen breakdown.

Authors:  B McARDLE
Journal:  Clin Sci       Date:  1951-02       Impact factor: 6.124

3.  Responses of N-terminal pro-brain natriuretic peptide (NT-proBNP) and cardiac troponin I (cTnI) to competitive endurance exercise in recreational athletes.

Authors:  C Vidotto; H Tschan; J Atamaniuk; R Pokan; N Bachl; M M Müller
Journal:  Int J Sports Med       Date:  2005-10       Impact factor: 3.118

Review 4.  Muscle stem cells and regenerative myogenesis.

Authors:  Iain W McKinnell; Gianni Parise; Michael A Rudnicki
Journal:  Curr Top Dev Biol       Date:  2005       Impact factor: 4.897

Review 5.  Mesenchymal stem cells: progress toward promise.

Authors:  K Le Blanc; Mf Pittenger
Journal:  Cytotherapy       Date:  2005       Impact factor: 5.414

Review 6.  Marrow stromal cells as stem cells for nonhematopoietic tissues.

Authors:  D J Prockop
Journal:  Science       Date:  1997-04-04       Impact factor: 47.728

7.  Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span.

Authors:  Hee Kyung Jin; Janet E Carter; George W Huntley; Edward H Schuchman
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

8.  Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study.

Authors:  M A Martín; J C Rubio; J Buchbinder; R Fernández-Hojas; P del Hoyo; S Teijeira; J Gámez; C Navarro; J M Fernández; A Cabello; Y Campos; C Cervera; J M Culebras; A L Andreu; R Fletterick; J Arenas
Journal:  Ann Neurol       Date:  2001-11       Impact factor: 10.422

Review 9.  Skeletal muscle injury induced by eccentric muscle action: muscle proteins as markers of muscle fiber injury.

Authors:  S Sorichter; B Puschendorf; J Mair
Journal:  Exerc Immunol Rev       Date:  1999       Impact factor: 6.308

10.  Bone marrow cells regenerate infarcted myocardium.

Authors:  D Orlic; J Kajstura; S Chimenti; I Jakoniuk; S M Anderson; B Li; J Pickel; R McKay; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Nature       Date:  2001-04-05       Impact factor: 49.962
View more
  20 in total

1.  Mesenchymal stem cells: A new diagnostic tool?

Authors:  Maria Teresa Valenti; Antonio Mori; Giovanni Malerba; Luca Dalle Carbonare
Journal:  World J Stem Cells       Date:  2015-06-26       Impact factor: 5.326

Review 2.  Stem cell homing in musculoskeletal injury.

Authors:  Eliza L S Fong; Casey K Chan; Stuart B Goodman
Journal:  Biomaterials       Date:  2010-10-08       Impact factor: 12.479

Review 3.  Mesenchymal stem cells: emerging therapy for Duchenne muscular dystrophy.

Authors:  Chad D Markert; Anthony Atala; Jennifer K Cann; George Christ; Mark Furth; Fabrisia Ambrosio; Martin K Childers
Journal:  PM R       Date:  2009-06       Impact factor: 2.298

4.  Mesenchymal stem cells in peripheral blood of severely injured patients.

Authors:  R Wiegner; N-E Rudhart; E Barth; F Gebhard; L Lampl; M S Huber-Lang; R E Brenner
Journal:  Eur J Trauma Emerg Surg       Date:  2017-10-06       Impact factor: 3.693

5.  Apoptotic endothelial cells demonstrate increased adhesiveness for human mesenchymal stem cells.

Authors:  Irina A Potapova; Ira S Cohen; Sergey V Doronin
Journal:  J Cell Physiol       Date:  2009-04       Impact factor: 6.384

Review 6.  Ossification of abdominal scar tissue: a case series with a translational review on its development.

Authors:  E M Fennema; J de Boer; W J Mastboom
Journal:  Hernia       Date:  2014-03-26       Impact factor: 4.739

Review 7.  Mesenchymal stem cell priming: fine-tuning adhesion and function.

Authors:  Dean P J Kavanagh; Joseph Robinson; Neena Kalia
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

8.  Circulating mesenchymal stem cells microparticles in patients with cerebrovascular disease.

Authors:  Suk Jae Kim; Gyeong Joon Moon; Yeon Hee Cho; Ho Young Kang; Na Kyum Hyung; Donghee Kim; Ji Hyun Lee; Ji Yoon Nam; Oh Young Bang
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

9.  Fate of bone marrow-derived stromal cells after intraperitoneal infusion or implantation into femoral bone defects in the host animal.

Authors:  Timothy Wilson; Christoffer Stark; Johanna Holmbom; Ari Rosling; Asko Kuusilehto; Teemu Tirri; Risto Penttinen; Erika Ekholm
Journal:  J Tissue Eng       Date:  2010-08-01       Impact factor: 7.813

10.  Intracellular trafficking and endocytosis of CXCR4 in fetal mesenchymal stem/stromal cells.

Authors:  Rebecca A Pelekanos; Michael J Ting; Varda S Sardesai; Jennifer M Ryan; Yaw-Chyn Lim; Jerry K Y Chan; Nicholas M Fisk
Journal:  BMC Cell Biol       Date:  2014-05-16       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.